Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

FDA clears Serevent Diskus

Oct. 3, 1997

Schering AG prepares new rolipram derivatives

Oct. 2, 1997

Dyax issued U.S. patent for novel elastase inhibitors

Oct. 2, 1997

Antileukotriene effects described for ebastine

Oct. 1, 1997

Peptidoleukotrienes and TxA2 both implicated in cough variant asthma

Oct. 1, 1997

Protective effects of Bayer's LTD4 antagonist demonstrated in asthmatic subjects

Oct. 1, 1997

Inhibitors of sCD23 production developed at SmithKline Beecham

Sep. 30, 1997

Zeneca describes SAR for new asthma therapy in development

Sep. 29, 1997

Arris reports data from phase IIa asthma trial

Sep. 26, 1997

CMI-947: new 5-LO inhibitor discovered at CytoMed

Sep. 26, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...